PortfoliosLab logoPortfoliosLab logo
ANGO vs. GRAB
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ANGO vs. GRAB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in AngioDynamics, Inc. (ANGO) and Grab Holdings Limited (GRAB). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ANGO achieves a -3.50% return, which is significantly higher than GRAB's -30.06% return.


ANGO

1D
1.98%
1M
3.94%
YTD
-3.50%
6M
-9.16%
1Y
23.65%
3Y*
4.49%
5Y*
-14.73%
10Y*
-0.81%

GRAB

1D
-2.24%
1M
-0.57%
YTD
-30.06%
6M
-32.63%
1Y
-22.27%
3Y*
2.93%
5Y*
-21.50%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

ANGO vs. GRAB - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
ANGO
AngioDynamics, Inc.
-3.50%40.17%16.84%-43.06%-50.07%79.91%7.81%
GRAB
Grab Holdings Limited
-30.06%5.72%40.06%4.66%-54.84%-44.56%8.16%

Correlation

The correlation between ANGO and GRAB is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.19

Correlation (3Y)
Calculated over the trailing 3-year period

0.18

Correlation (5Y)
Calculated over the trailing 5-year period

0.17

Correlation (All Time)
Calculated using the full available price history since Dec 1, 2020

0.16

Fundamentals

Market Cap

ANGO:

$515.37M

GRAB:

$15.50B

EPS

ANGO:

-$0.76

GRAB:

$0.09

PS Ratio

ANGO:

1.63

GRAB:

4.25

PB Ratio

ANGO:

2.97

GRAB:

2.38

Total Revenue (TTM)

ANGO:

$313.73M

GRAB:

$3.55B

Gross Profit (TTM)

ANGO:

$167.69M

GRAB:

$1.55B

EBITDA (TTM)

ANGO:

-$6.81M

GRAB:

$481.00M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ANGO vs. GRAB — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ANGO
ANGO Risk / Return Rank: 5858
Overall Rank
ANGO Sharpe Ratio Rank: 6161
Sharpe Ratio Rank
ANGO Sortino Ratio Rank: 5555
Sortino Ratio Rank
ANGO Omega Ratio Rank: 5656
Omega Ratio Rank
ANGO Calmar Ratio Rank: 6060
Calmar Ratio Rank
ANGO Martin Ratio Rank: 5959
Martin Ratio Rank

GRAB
GRAB Risk / Return Rank: 2121
Overall Rank
GRAB Sharpe Ratio Rank: 1616
Sharpe Ratio Rank
GRAB Sortino Ratio Rank: 1717
Sortino Ratio Rank
GRAB Omega Ratio Rank: 1818
Omega Ratio Rank
GRAB Calmar Ratio Rank: 2626
Calmar Ratio Rank
GRAB Martin Ratio Rank: 2727
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ANGO vs. GRAB - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for AngioDynamics, Inc. (ANGO) and Grab Holdings Limited (GRAB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ANGOGRABDifference
Sharpe ratioReturn per unit of total volatility

+1.14

Sortino ratioReturn per unit of downside risk

+1.66

Omega ratioGain probability vs. loss probability

1.13

0.93

+0.21

Calmar ratioReturn relative to maximum drawdown

0.82

-0.45

+1.28

Martin ratioReturn relative to average drawdown

1.63

-0.79

+2.43

ANGO vs. GRAB - Sharpe Ratio Comparison

The current ANGO Sharpe Ratio is 0.55, which is higher than the GRAB Sharpe Ratio of -0.59. The chart below compares the historical Sharpe Ratios of ANGO and GRAB, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ANGO vs. GRAB - Drawdown Comparison

The maximum ANGO drawdown since its inception was -83.04%, roughly equal to the maximum GRAB drawdown of -86.46%. Use the drawdown chart below to compare losses from any high point for ANGO and GRAB.


Loading charts...

Drawdown Indicators


ANGOGRABDifference

Max Drawdown

Largest peak-to-trough decline

-83.04%

-86.46%

+3.42%

Max Drawdown (1Y)

Largest decline over 1 year

-28.89%

-49.30%

+20.41%

Max Drawdown (3Y)

Largest decline over 3 years

-51.47%

-49.30%

-2.17%

Max Drawdown (5Y)

Largest decline over 5 years

-82.98%

-86.46%

+3.48%

Max Drawdown (10Y)

Largest decline over 10 years

-82.98%

Current Drawdown

Current decline from peak

-60.12%

-79.54%

+19.42%

Average Drawdown

Average peak-to-trough decline

-47.82%

-67.38%

+19.56%

Ulcer Index

Depth and duration of drawdowns from previous peaks

14.51%

28.07%

-13.56%

Volatility

ANGO vs. GRAB - Volatility Comparison

AngioDynamics, Inc. (ANGO) has a higher volatility of 11.94% compared to Grab Holdings Limited (GRAB) at 11.12%. This indicates that ANGO's price experiences larger fluctuations and is considered to be riskier than GRAB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ANGOGRABDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.94%

11.12%

+0.82%

Volatility (6M)

Calculated over the trailing 6-month period

35.41%

25.26%

+10.15%

Volatility (1Y)

Calculated over the trailing 1-year period

43.08%

37.92%

+5.16%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

53.88%

59.94%

-6.06%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

47.93%

60.39%

-12.46%

Dividends

ANGO vs. GRAB - Dividend Comparison

Neither ANGO nor GRAB has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ANGO vs. GRAB - Financials Comparison

This section allows you to compare key financial metrics between AngioDynamics, Inc. and Grab Holdings Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M1.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
78.42M
955.00M
(ANGO) Total Revenue
(GRAB) Total Revenue
Values in USD except per share items

ANGO vs. GRAB - Profitability Comparison

The chart below illustrates the profitability comparison between AngioDynamics, Inc. and Grab Holdings Limited over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-60.0%-40.0%-20.0%0.0%20.0%40.0%60.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
52.9%
43.4%
Portfolio components
ANGO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AngioDynamics, Inc. reported a gross profit of 41.48M and revenue of 78.42M. Therefore, the gross margin over that period was 52.9%.

GRAB - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Grab Holdings Limited reported a gross profit of 414.00M and revenue of 955.00M. Therefore, the gross margin over that period was 43.4%.

ANGO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AngioDynamics, Inc. reported an operating income of -3.76M and revenue of 78.42M, resulting in an operating margin of -4.8%.

GRAB - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Grab Holdings Limited reported an operating income of 75.00M and revenue of 955.00M, resulting in an operating margin of 7.9%.

ANGO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AngioDynamics, Inc. reported a net income of -8.08M and revenue of 78.42M, resulting in a net margin of -10.3%.

GRAB - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Grab Holdings Limited reported a net income of 136.00M and revenue of 955.00M, resulting in a net margin of 14.2%.


Frequently Asked Questions


ANGO and GRAB have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ANGO has higher volatility (11.94%) compared to GRAB (11.12%). In terms of maximum drawdown, ANGO dropped -83.04% vs GRAB's -86.46%.

ANGO currently has the higher Sharpe Ratio (0.55 vs -0.59), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ANGO and GRAB

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer